FOUZIA KHAN

Concepts (56)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Vagina
2
2024
207
0.940
Why?
Premature Birth
2
2024
418
0.780
Why?
Microbiota
2
2024
435
0.730
Why?
HIV Infections
1
2024
2043
0.360
Why?
Irritants
1
2025
8
0.230
Why?
Urinary Bladder, Overactive
1
2025
29
0.220
Why?
Pharmacology
1
2023
6
0.200
Why?
Placenta
1
2024
495
0.150
Why?
Pregnancy Complications, Infectious
1
2024
502
0.150
Why?
Curriculum
1
2023
792
0.130
Why?
Gastrointestinal Microbiome
1
2024
828
0.120
Why?
Cell- and Tissue-Based Therapy
1
2017
150
0.110
Why?
Lansoprazole
1
2015
26
0.110
Why?
Pregnancy
2
2024
7390
0.110
Why?
Upper Extremity
1
2015
52
0.110
Why?
Vasodilation
1
2015
175
0.100
Why?
Peripheral Arterial Disease
1
2017
324
0.090
Why?
Proton Pump Inhibitors
1
2015
275
0.090
Why?
Coronary Disease
1
2015
627
0.090
Why?
Female
5
2025
70239
0.060
Why?
Chocolate
1
2025
2
0.060
Why?
Citrus
1
2025
5
0.060
Why?
Sweetening Agents
1
2025
37
0.050
Why?
Lactobacillus
1
2024
41
0.050
Why?
Mouth
1
2024
68
0.050
Why?
Humans
6
2025
130074
0.050
Why?
Aldehyde Dehydrogenase
1
2017
41
0.030
Why?
Intermittent Claudication
1
2017
48
0.030
Why?
Extremities
1
2017
73
0.030
Why?
Perfusion
1
2017
209
0.030
Why?
Bone Marrow Cells
1
2017
243
0.030
Why?
California
1
2015
127
0.030
Why?
Cross-Over Studies
1
2015
239
0.030
Why?
Bone Marrow Transplantation
1
2017
589
0.030
Why?
Drug Administration Schedule
1
2015
723
0.020
Why?
Administration, Oral
1
2015
706
0.020
Why?
Arginine
1
2015
336
0.020
Why?
Comorbidity
1
2017
1584
0.020
Why?
Infant, Newborn
1
2024
8547
0.020
Why?
Exercise
1
2017
881
0.020
Why?
Pilot Projects
1
2015
1439
0.020
Why?
Predictive Value of Tests
1
2015
2289
0.020
Why?
Reproducibility of Results
1
2015
2891
0.020
Why?
Follow-Up Studies
1
2017
5166
0.020
Why?
Quality of Life
1
2017
2069
0.020
Why?
Middle Aged
2
2017
28314
0.010
Why?
Risk Assessment
1
2015
3677
0.010
Why?
Biomarkers
1
2015
3358
0.010
Why?
Time Factors
1
2015
6165
0.010
Why?
Prospective Studies
1
2015
6401
0.010
Why?
Risk Factors
1
2017
10959
0.010
Why?
Treatment Outcome
1
2017
12818
0.010
Why?
Young Adult
1
2015
9978
0.010
Why?
Male
2
2017
64380
0.010
Why?
Aged
1
2017
20821
0.010
Why?
Adult
1
2015
31011
0.010
Why?
KHAN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (56)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_